IN BRIEF: Arix Bioscience investee Pyxis Oncology prices Nasdaq IPO
IN BRIEF: Arix Bioscience investee Pyxis Oncology prices Nasdaq IPO
Read moreIN BRIEF: Arix Bioscience investee Pyxis Oncology prices Nasdaq IPO
Read moreEXECUTIVE CHANGES: Arix confirms CEO; Schroder RE picks new chair
Read moreCORRECT: Arix investee doses first patient in tumour drug trial
Read moreIN BRIEF: Arix doses first patient in tumour-specific drug trial
Read moreArix Bioscience portfolio value falls as stock picks struggle
Read moreUK earnings, trading statements calendar - next 7 days
Read moreEXECUTIVE CHANGES: TP's interim CEO; National Grid taps Meggitt chief
Read moreUK shareholder meetings calendar - next 7 days
Read moreIN BRIEF: Arix investee Harpoon presents updated data for HPN424
Read moreUK shareholder meetings calendar - next 7 days
Read moreEXECUTIVE CHANGES: Prudential names board of Jackson Financial
Read moreCORRECT (Apr 27): Arix portfolio firm partners with Daiichi, CANbridge
Read moreIN BRIEF: Arix partners with Daiichi Sankyo, CANbridge Pharmaceuticals
Read moreEXECUTIVE CHANGES: Ebiquity appoints ITV executive Izlan to board
Read moreIN BRIEF: Arix Bioscience investee Artios collaborates with Novartis
Read more